FFA Metabolism in Different Types of Human Obesity

This study has been withdrawn prior to enrollment.
Information provided by:
Mayo Clinic
ClinicalTrials.gov Identifier:
First received: September 10, 2003
Last updated: April 29, 2015
Last verified: April 2015

We will give intravenous fat molecules to help us understand how the fat that is released from peoples fat cells is used. This will be done when people are eating, not eating and walking.


Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: FFA Metabolism in Different Types of Human Obesity

Further study details as provided by Mayo Clinic:

Enrollment: 0
Study Start Date: November 2003
Study Completion Date: February 2004
Primary Completion Date: January 2004 (Final data collection date for primary outcome measure)

Ages Eligible for Study:   18 Years to 50 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes

Inclusion Criteria: BMI 28-36 -upper body obesity and lower body obesity non-obese BMI 19-24. Females premenopausal. Must be a non-smoker.

Exclusion Criteria: BP> 160/95 on HTN meds, known systemic illness. Medications that affect fat metabolism. We do no cover travel expenses. Known heart and vascular disease.

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00068900

United States, Minnesota
Mayo Clinic
Rochester, Minnesota, United States, 55905
Sponsors and Collaborators
Mayo Clinic
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00068900     History of Changes
Other Study ID Numbers: FFAMET - dk40484 (withdrawn)
Study First Received: September 10, 2003
Last Updated: April 29, 2015
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
Body Weight
Nutrition Disorders
Signs and Symptoms

ClinicalTrials.gov processed this record on October 09, 2015